gist

(redirected from Gastrointestinal stromal tumour)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.

gist

(Ground for a suit), noun alleged reason, base, basis, basis of argument, basis of litigation, cardinal point, cause, cause of action, essential ground, essential matter, essential part, focal point of the complaint, foundation of a suit, gravamen, gravamen of a charge, gravamen of the complaint, great point, ground, important point, keystone, main charge, main point, object of the action, pith of a matter, point, principal part, principal point, reason, reason for which suit is commenced, salient point, substance, substantial part of a complaint, sum and substance, ultimate cause
Associated concepts: gist of a cause of action, gist of an offense, gist of the complaint

gist

(Substance), noun backbone, basis, broad meaning, connotation, core, drift, essence, essential meaning, essential part, fundamentals, general meaning, idea conveyed, import, index, intrinsic nature, marrow, matter, pith, primary meaning, purport, quiddity, quintessence, real content, reality, root, sense, spirit, substantial meaning, sum and substance, tenor, true meaning, vital principle
See also: center, connotation, content, contents, context, essence, gravamen, import, main point, meaning, significance, signification, spirit, subject, substance, sum, tenor

gist

the essential point of an action.

GIST, pleading. Gist of the action is the essential ground or object of it, in point of law, and without which there is no cause of action. Gould on Pl. c. 4, Sec. 12. But it is observable that the substance or gist of the action is not always the principal cause of the plaintiff Is complaint in point of fact, nor that on which he recovers all or the greatest part of his damages.
     2. It frequently happens that upon that part of his declaration which contains the substance or gist of the, action, he only recovers nominal damages, and he gets his principal satisfaction on account of matter altogether collateral thereto. A familiar instance of this is the case where a father sues the defendant for a trespass for the seduction of his daughter. The gist of the action is the trespass, and the loss of his daughter's services, but the collateral cause is the injury done to his feelings, for which the principal damages are given. In stating the substance or gist of the action, every thing must be averred which is necessary to be proved at the trial. Vide 1 Vin. Ab. 598; 2 Phil. Ev. 1, note. See Bac. Abr. Pleas, B; Doct. P. 85. See Damages, special, in pleading; 1 Vin. At. 598; 2 Phil. Ev. 1, n.

References in periodicals archive ?
Laparoscopic excision of large lower rectal gastrointestinal stromal tumour (GIST): A case report.
CD117: a sensitive marker for gastrointestinal stromal tumours that is more specific than CD34.
1) Gastrointestinal stromal tumours (GISTs) are rare, accounting for less than 3% of all gastrointestinal neoplasms and less than 6% of all sarcomas.
Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience.
Gastrointestinal stromal tumours (GIST) are a rare disease that metastasises in up to 85% of patients with subsequent median progression-free survival (PFS) of only around 30 months.
Gastrointestinal stromal tumours (GIST) account for 1-3% of all resected gastric tumours and are the most common solitary, asymptomatic submucosal masses found in the stomach.
Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neuroibromatosis type 1.
The summit will also focus on a selection of rare cancers in the wake of new advancements in medical management, such as chronic myeloid leukemia (CML), a cancer of the bone marrow, gastrointestinal stromal tumours (GIST), which is a rare cancer of the stomach and gut, and neuroendocrine tumors (NET), a tumor that starts in the small bowel and spreads to the heart.
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.
Glivec (imatinib) is already recommended as a treatment for patients with gastrointestinal stromal tumours (Gist) that cannot be removed by surgery.
Kidney cancer affects 6,600 UK patients a year, and 1,000 suffer from gastrointestinal stromal tumours, which Sutent also benefits.

Full browser ?